Molecular imaging of plaque vulnerability

Area of Science:

• Cardiovascular Imaging
• Molecular Imaging
• Atherosclerosis Research

Background:

• Atherosclerosis involves complex vessel wall biology and the development of vulnerable plaques.
• Identifying vulnerable plaques is crucial for preventing cardiovascular events.
• Current pre-clinical imaging strategies show promise for clinical translation.

Observation:

• Significant progress in novel imaging strategies targeting vessel wall biology over the last decade.
• Few molecular imaging techniques, including (18)F-FDG and (18)F-NaF PET, have progressed to clinical evaluation.
• These clinical studies demonstrate promising results in identifying plaque characteristics.

Findings:

• Molecular imaging targets key pathobiological mechanisms associated with atherosclerotic plaque vulnerability.
• Specific PET imaging tracers like (18)F-FDG and (18)F-NaF are being explored for clinical use.
• These imaging modalities aid in understanding the biological drivers of plaque instability.

Implications:

• Enhanced identification of vulnerable plaques can lead to more personalized treatment strategies.
• Clinical translation of advanced imaging techniques offers new diagnostic and prognostic capabilities.
• Further research in molecular imaging will refine our understanding and management of atherosclerosis.